This past Wednesday, battered-down CannTrust Holdings (TSX:TRST)(NYSE:CTST) shares staged a major comeback, rallying 10% in the morning before cooling off later in the day. It’s not clear why investors are suddenly warming up to the stock, because its regulatory problems are far from over. Possibly, investors are beginning to see TRST as a bargain, as it has become the cheapest stock in the marijuana space by far.

But between the 5,000 kg hold imposed by Heath Canada and the 7,500 kg hold the company imposed on itself, CannTrust is going to have a hard time selling pot this quarter — that’s without even getting in to the possibility of fines and other penalties.

New York Gov. Andrew Cuomo signed a bill to decriminalize cannabis use and expunge all criminal penalties for possession of 2 ounces or less of marijuana. Meanwhile, Sen.

British economists, politicians and marijuana legalization advocates have criticized the Canadian cannabis model after conducting a research trip to Ontario.

Volte Face, a campaign group that aims to see cannabis legalized in the UK, took a cross-party group of MPs across the Atlantic on a fact-finding mission. It also brought Chris Snowden, head of lifestyle economics at a think-tank called the Institute for Economic Affairs, along for the ride.

Over the past year, we've seen a pretty big, but important, shift in the marijuana industry. No longer are promises good enough for investors to send cannabis stocks higher. Nowadays, with Canada having legalized adult-use marijuana, and two-thirds of U.S. states giving the green light to medical cannabis, earnings actually matter.

With the marijuana business hitting new ― ahem ― highs on a daily basis, one of the biggest headaches in the business is simply finding a name for your cannabis company that someone hasn’t already used. And one that isn’t totally lame.

Not to mention like with any new business with no brand recognition, you need to make yourself stand out. With that kind of pressure, it’s inevitable some efforts will go wrong.

Oklahoma’s Treehouse Dispensary was recently in the news after Canadian media company Nelvana took legal action against it, for using an almost perfect facsimile of the Treehouse TV logo.

Besides being a cringeworthy and blatant ripoff, using the logo of a TV channel for small children to sell weed raises questions about your target clientele.

In the wake of the most recent scandal within the marijuana industry, CannTrust  (TSX:TRST)(NYSE:CTST) has become a headline focus over the last two weeks.

The company is under fire after Health Canada’s audit, where they discovered five unlicensed rooms in its Niagara Facility where CannTrust had been growing marijuana.

The company now has a significant quantity of its cannabis inventory on hold while Health Canada probes further into the matter and reviews whether CannTrust should lose its license. Similar to a series of falling dominos, the bad news broke out again and again, sending shares tumbling.

Whether you realize it or not, the marijuana industry is a big-money business. Although "only" $10.9 billion in legal sales were recognized in global licensed cannabis stores last year, we know that tens of billions of dollars in sales are occurring in the black market. As more and more countries legalize, it provides an opportunity for consumers to be moved from illicit to legal channels.

It’s a scorching-hot summer with record-high temperatures being recorded around the world. But don’t tell that to weed stock investors, who’ve been left out in the cold after a series of disappointing earnings reports and regulatory scandals. In the past two months, all major producers have seen their share prices fall, while marijuana stocks as a class are down about 11%.

With that said, the weed industry’s current woes aren’t affecting all stocks equally. While some are way down, others are still up for the year, and many are actually in fairly good shape compared to where they were last fall. However, there are definitely some major weed producers that are struggling right now. The following are two you can consider selling in August.

There are several trains of thought when it comes to cannabis investing at the moment. While the serious capital gains enjoyed by traders in 2018 seem to have been consigned to recent history, investors are now eyeing stocks that could cash in on the coming legalization of edibles and other peripheral marijuana products this fall.

Although there are a lot of industries expected to deliver big-time growth over the next decade, cannabis might be the kingpin of them all. The industry generated nearly $11 billion in global marijuana sales in 2018, and various Wall Street forecasts are calling for between $50 billion and $200 billion in full-year salesby 2029/2030. No matter how you cut it, the worldwide legal cannabis annual growth rate is expected to be in the double digits.